The Chronicle of Higher Education

U.S. Rejects Wisconsin's Patents on Stem-Cell Technology, but University Vows to Appeal

By GOLDIE BLUMENSTYK

In a preliminary finding, the U.S. Patent and Trademark Office has determined that three broad patents issued to the University of Wisconsin at Madison on a technique for isolating and maintaining embryonic stem cells were issued in error because the technique wasn't really new.

In...

To continue reading this premium article, you must have a Chronicle account AND a subscription or an online pass.

Subscriptions start at $40; Web passes for under $10.